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Background: The Georgia Charitable Care Network (GCCN) is a non-profit organization whose primary mission is to foster 
collaborative partnerships to deliver compassionate health care to low-income, uninsured individuals. Hypertension screening 
and management is a service provide by 90+ clinics in the GCCN statewide. 
 
Methods: With data from N=1661 patients who were screened and treated for hypertension at n=12 clinics in 2013, the 
impact of hypertension management on blood pressure levels, the incidence of coronary heart disease (CHD) and stroke, and 
utilization of emergency departments (EDs) were examined. The resulting changes in healthcare utilization were converted to 
changes in healthcare costs and compared to the expenditures for clinics providing screening and treatment services to the 
same population over a one-year period. 
 
Results: Patients with an initial diagnosis of hypertension or prehypertension experienced average reductions of 10.27 mmHg 
and 6.32 mmHg in systolic and diastolic blood pressure, respectively, during their follow-up visits. These changes were 
associated with 32.0% and 44.3% reductions in the relative risk of CHD and stroke, respectively. The savings from this 
reduction in blood pressure and avoided ED visits for 1661 hypertensive patients produced positive net benefits in 2013 US$, 
of more than $400,000, with a benefit-cost ratio of 1.6. 
 
Conclusions: For every dollar invested in GCCN clinics for hypertension screening and management, there is a benefit to the 
healthcare system through reduced costs of $1.60. GCCN clinics are a cost-saving delivery model for underserved 
communities with poor health status and high ED usage. 
 





Charitable clinics have long worked at the local level to 
address needs of the uninsured through a wide range of free 
and nearly free primary healthcare services, often with the 
goal to prevent and manage disease before patients require 
emergency care or are hospitalized. These clinics deliver a 
variety of services, including primary, preventive, and 
specialty care, and provide an important safety net for low- 
income, uninsured, and underserved populations in  both 
rural and urban communities. In Georgia, there are more 
than 100 independent, not-for-profit charitable clinics and 
hundreds of physicians, dentists, and other health care 
professionals who provide charitable care throughout the 
state. Each is dedicated to serving, through the  GCCN, 
many of the more than 1.8 million uninsured in Georgia 
(Smith & Medalia, 2014). 
 
At the federal level, the Affordable Care Act (ACA) was 
passed, in part, to address the needs of the uninsured 
through Medicaid expansion and federal health insurance 
subsidies for individuals below 400% of the poverty line. 
Despite these efforts, it has been estimated that 20 million 
individuals will remain uninsured after the ACA is fully 
implemented (Chazin et al, 2010). In Georgia, where the 
political leadership has decided to forego Medicaid 
expansion, hundreds of thousands of citizens remain 
uninsured, at a rate considerably higher than the national 
average (Georgia Budget Policy Institute, 2015). Therefore, 
clinics within GCCN will continue to be essential providers 
of healthcare access to Georgia’s vulnerable populations. 
 
A fundamental challenge faced by charitable clinics is to 
demonstrate to funders that they have a clinical and 
economic impact within their communities. Clinics often 
lack the resources to collect patient outcome data over time 
and the expertise to assess economic return on investment. 
Because nonprofit organizations serving the under- and 
uninsured have limited resources with which to deliver the 
costly care associated with populations encountering 
barriers to access (Bicki et al, 2013), it is necessary for these 
health care clinics to understand and empirically evaluate 
the economic impact of effectively delivering primary care 
to their clinic population. Funders of these organizations, 
RESEARCH AND PRACTICE 
J Ga Public Health Assoc (2015) Vol. 5, No. 2 




such as local businesses and/or hospitals serving the same 
community, may also ask for (or require) information on 
how their resources are spent and the economic returns for 
those resources expended. In this study, longitudinal data 
provided by clinics were used to assess the economic impact 
of treating and managing patients in the GCCN. 
 
GCCN Clinics 
GCCN member clinics include both charitable and free 
clinics, and the network is diverse in terms of size, model, 
and scope of services provided. Charitable clinics are not- 
for-profit, community-based health centers that provide 
services to uninsured, underserved, and vulnerable 
populations. Most offer preventive services and fund their 
operations through grants, patient fees, and donations. 
Although charitable clinics may serve the publicly insured, 
they do not receive enhanced reimbursements from 
Medicaid. Patients may pay a flat rate or a fee based on a 
sliding scale. Free clinics represent 63% of all GCCN 
clinics and provide healthcare services at no cost to patients. 
These clinics utilize a volunteer/staff model and provide a 
range of medical, dental, pharmacy, optical, and behavioral 
health services to economically disadvantaged individuals. 
Free clinics restrict eligibility to the uninsured or individuals 
with limited access to primary care, specialty care, or 
pharmaceuticals. These clinics are often community- 
supported and are funded primarily by private donations and 
foundations. Most personnel at charitable and free clinics 
are volunteers, including physicians, dentists, and other 
specialty providers from private practices and hospitals. 
 
GCCN clinics, located  in 90 of Georgia’s 159  counties, 
provide various healthcare services: 46% provide dental or 
vision services; 86% provide prescription assistance; 83% 
provide health education; and 34% provide mental health 
services. On average, clinics are open 20 hours per week 
and receive 4200 hours of volunteer labor each year. Most 
of the population served by GCCN clinics can be 
characterized as the sick and the working poor. Most 
patients are employed, and 80% have one or more chronic 
illness requiring extensive and ongoing medical treatment, 
coordination of care, and patient education. 
 
Since hypertension is the most common diagnosis for 
patients served by GCCN clinics, this study focuses on the 
cost-savings to the healthcare system for the identification, 
treatment, and management of hypertension. To our 
knowledge, this is the first economic evaluation to assess 
the cost-savings from lowering blood pressure and reducing 
emergency department (ED) usage through the treatment of 





Participating GCCN clinics (n=95) were contacted and 
access to the following data was requested for the 2013 
calendar year: a) annual operating expenditures; b) number 
of unique patients served annually; c) number of patient 
visits annually; d) number of hypertension screenings 
performed; and e) for newly diagnosed  hypertensive 
patients, blood pressure at the time of screening and at a 1- 
year follow-up. Eight clinics were excluded, as they were 
not in operation for the entire year of 2013. Data on the 
number of patients  served and/or  the number of  patient 
visits were received from n=53 clinics, or 61% of the 
network. Annual operating costs or costs per visit were 
obtained for n=18 clinics (21%); and data specific to 
hypertension management was received from n=12 clinics 
(14%). Locations of the clinics that provided detailed 
patient-level data on hypertension management are shown in 
Figure 1. They represent 12 of the 18 public health districts 
across the state of Georgia. The clinics include: Bethesda 
Community Clinic in Cherokee County, the Free Clinic of 
Rome in Floyd County; Good News Clinics in Hall County; 
Good Shepherd Clinic in Clayton County; Macon Volunteer 
Clinic in Bibb County; Partnership Health Center in 
Lowndes County; Physicians’ Care Clinic in DeKalb 
County; Rock Springs Clinic in Lamar County; The Care 
Place in Douglas County; Mercy Medical Clinic in Toombs 
County; Gwinnett Community Clinic in Gwinnett County; 
and the Athens Nurses Clinic in Clarke County. 
 
Figure 1. Location of clinics providing data on HTN 
patients 
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Table 1 provides descriptive statistics from all participating clinics, and Table 2 provides descriptive statistics for the n=1661 
hypertensive patients visiting the 12 GCCN clinics. 
 
Table 1. Descriptive Statistics of Data Received from Clinics 
 
# of Clinics 
 
# of Patients in 2013 
(range) 









 Mean: 2114    
48 Median: 782    
 (128-12502)    
  Mean: 6847   
50  Median: 4123   
  (306-32122)   
   Mean: 438,971 Mean: 88 
18   Median: 283,429 Median: 70 
   (41523-2.9 million) (9.37-313.90) 
 
 
Table 2. Descriptive Statistics for the Hypertensive Patients from N=12 Clinics 
 
# of Hypertension 
Patients 
# of Hypertension 
Visits/Year (from n=4 
clinics only) 
 
Initial Blood Pressure 
 
Follow-up Blood Pressure at 12 Mos. 
Systolic Diastolic Systolic Diastolic 
Mean: 138.42 Mean: 5.5     
Range: 49-283 Median: 5 147.9 90.8 137.71 84.49 
Total: 1661 patients Range: 2-25     
 
 
The perspective of this analysis was that of the healthcare 
system; that is, expenditures and avoided costs were those 
accrued by the healthcare system only (regardless of payer). 
The study period was one year, making discounting of costs 
unnecessary. All costs  were inflated to  2013 US dollars 
using the medical component of the consumer price index 
(US Department of Labor, 2014). 
 
Analysis of Coronary Heart Disease (CHD) and Stroke 
Events and Costs Averted 
Following the methodology outlined by Song et al. (2013), 
who estimated the cost savings of hypertension screening in 
mobile clinics, the reductions in the risk of CHD events and 
stroke that result from reductions in blood pressure were 
examined. To determine the incidence of a CHD event in 
Georgia for a hypertensive patient, rates from Georgia’s 
Online Analytic Statistical Information System (OASIS) 
database (Georgia Department of Public Health, 2015) were 
used for diagnoses of high blood pressure,  hypertensive 
heart disease, obstructive heart disease including heart 
attack, and aortic aneurism. As a proxy for CHD incidence, 
because these data were not available otherwise, the 2013 
annual hospital discharge rates and death rates for the 
aforementioned diagnoses were summed, resulting in an 
estimate of 7.9 cases of CHD per 1000 person-years for ages 
50-59 years, including all races and genders. Song et al. 
(2013) used a CHD incidence of 11.4 per 1000 person- 
years, which was incorporated into the sensitivity analysis. 
 
Because the OASIS database does not differentiate by type 
of stroke, both ischemic and hemorrhagic events were 
included in the definition of stroke, as did Song et al. 
(2013). For a baseline annual incidence of stroke, 3.2 per 
1000 person-years was used, which is equal to the 2013 rate 
of hospital discharges and deaths for stroke in persons aged 
50-59, including all races and genders. This estimate is 
similar to other estimates used previously, including that by 
Song et al. (2013), which was 3.3 per 1000 person-years. 
 
To estimate the proportion of CHD and stroke events that 
could be prevented with management of hypertension, the 
results of a meta-analysis by Law et al. (2009), which were 
also incorporated into the study by Song et al. (2013), were 
used. The regression coefficients for the meta-analysis were 
based on studies of blood pressure measured at baseline 
with a minimum follow-up of 6  months. Data on blood 
pressure change are from the sample of n=1661 patients at 
the 12 clinics (Table 2). Following Song et al. (2013), these 
reductions should have been adjusted for age, race, sex, and 
comorbidity status. However, we used unadjusted estimates, 
as these patient-level attributes were not available for this 
sample. With the equations below, the relative risk 
reductions for CHD and stroke events resulting from 
hypertension management and treatment were estimated. 
These risk reductions were then applied to the clinic 
population to estimate the number of CHD and stroke 
events averted. 
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To apply unit costs to CHD and stroke events averted, 
estimates from the Coronary Heart Disease Policy Model 
were used. This is a validated model that has been used for 
over two decades to assess effects and costs of different 
CHD prevention and treatment strategies (Moran et al., 
2015; Weinstein et al., 1987). For each CHD event, the 
costs of fatal and not-fatal hospitalizations from acute 
myocardial infarction plus 1-year follow-up costs ($44,000 
for non-fatal and $46,000 for fatal, in 2010 US$) were used. 
These costs were inflated to 2013 US$ and weighted to 
reflect the data on incidence of fatal and not-fatal CHD 
events from Georgia’s OASIS data (14% and 86%, 
respectively), yielding a final estimate of $53,377. For each 
stroke event, hospitalization and one-year follow-up costs 
for fatal and not-fatal strokes ($37,000 for non-fatal stroke 
and $26,000  for  fatal strokes, in  2010  US$) were used. 
These costs were weighted to reflect the data on incidence 
of fatal and not-fatal strokes from Georgia’s OASIS data 
(8% and 92%, respectively), thus equaling $39,437 (2013 
US$). 
 
Analysis of ED Utilization and Costs Averted 
Following the methodology of Song et al. (2013), how 
GCCN hypertension management reduced ED utilization 
and costs was also considered. Following Bicki et al. 
(2012), the assumption was that 49%, or n=814,  of  the 
initial hypertension visits resulted in an avoided ED visit. 
For the sensitivity analysis, the assumption was that the 
best-case scenario would be that 78% of first-time clinic 
visits resulted in an avoided ED visit, based on a small study 
conducted in the Athens Nurses Clinic (personal 
communication, August 26, 2015). In the worst-case 
scenario, 34.5% of first-time ED visits were assumed to be 
averted (Nadkarni & Philbrick, 2003). For the unit cost of 
an ED visit, $951 was used. This was derived from data of 
the Agency for Healthcare Research and Quality, 2008 
Medical Expenditure Panel Survey showing expenditures 
for an ED visit with no surgery=$821 (in 2008$) inflated 
to 2013$ (Machlin & Chowdhury, 2011). For the worst-
case scenario, $413 was used, the reported cost of an ED 
visit for a sore throat and flu symptoms at Athens Regional 
Medical Center, where a 40% discount was applied for 
being uninsured (Georgia Health News, 2013). 
 
Estimating Cost-Savings 
Cost-savings were estimated by first summing the savings 
associated with reduced CHD and stroke events and 
reductions in ED utilization and then comparing these 
savings to the GCCN expenditures for treating hypertensive 
patients. From the data collected (Table 2), each 
hypertension patient was estimated to have visited the clinic 
on average 5.5 times in the year. The average cost for a 
GCCN visit, as estimated in Table 1, was $88. However, 
because this mean was influenced by outliers, we eliminated 
all cost per visit values that were +/- 3 standard deviation 
points from the mean, thus eliminating n=1 cost per clinic 
value ($314/visit). The adjusted mean was $75 per visit. 
 
The cost-savings summary measures included are common 
in the field of economic evaluation, including net-benefits 
(NBs), the benefit-cost (BC) ratio, and return on investment 
(ROI) (Haddix et al., 2003). NBs are calculated by 
subtracting expenditures of a program from an estimate of 
its monetary benefits or savings. An NB result >0 suggests 
that there is an economic rationale for funding a program. 
BC ratios are calculated by dividing a program’s benefits or 
savings by its expenditures. A BC ratio >1 suggests that 
there is an economic rationale for funding a program. 
Finally, ROI is calculated by dividing a program’s estimate 
of NB by its expenditures. Like the NB measure, an ROI >0 




For the 1661 patients in the sample, the reductions in 
systolic and diastolic blood pressure were associated with a 
32.0% reduction in CHD events and a 44.3% reduction in 
strokes. Using the unit cost per case averted, the reduction 
in incidence was estimated to save $318,832 from blood 
pressure reductions over the one-year study period for the 
1661 hypertensive patients in the sample (Table 3). 
 
With each avoidable ED visit costing an average of $951, 
there was an estimated total savings of $774,114 from the 
814 estimated ED visits avoided for the sample of 1661 
patients. This means that, for every 100 patients who visit a 
GCCN clinic annually, the healthcare system saves more 
than $50,000 in avoided ED visits. 
 
In 2013, GCCN savings were $1,092,946 for the sample of 
1661 hypertension patients; GCCN expenditures for treating 
these patients in the same period were $685,163 (Table 3). 
The NBs were $407,783 and the BC ratio was 1.6 (Table 3). 
The ROI calculation was slightly different in that it 
compared NB divided by expenditures. For these results, the 
ROI was 0.6, or a 60% return on investment. 
 
With a sensitivity analysis, savings, expenditures, and cost- 
savings for a best-case and worst-case scenario were 
estimated. For the best-case scenario, all parameter 
estimates in favor of GCCN, where available, were used; in 
the worst-case scenario, all estimates against GCCN, where 
available, were used. In the best-case scenario, benefits 
exceeded costs by more than $1 million, and the ratio of 
benefits to costs was 2.9 (Table 3). These results imply that, 
for each $1 spent in the best-case scenario, savings were 
$2.90, representing a 190% return on investment. In the 
worst-case scenario, benefits did not exceed costs, and for 
each $1 spent, savings were only $0.63, representing a 37% 
loss on investment. However, these losses occurred only 
when both ED visits avoided and ED unit costs were at their 
J Ga Public Health Assoc (2015) Vol. 5, No. 2 




lowest estimates. When the percent of ED visits avoided 
was varied (from 34.5% to 78%) without varying any other 
parameter, the BC ratio rose to a favorable range of 1.26 to 
2.26. When the  cost of an ED visit was varied without 
varying any other parameter, any ED unit cost >$450 
resulted in a positive NB. 
 
 
Table 3. Calculation of Return on Investment in the GCCN 
Category Baseline Best Case Worst Case 
Blood Pressure Reduction 
CHD Avoided 
Baseline annual incidence (per 1000) 
Preventable fraction (percent) 
CHD cases avoided for the sample 
(n=1661) 
Total CHD cost per case 
Total CHD costs avoided 
Stroke Avoided 
Baseline annual incidence (per 1000) 
Preventable fraction (percent) 
Stroke cases avoided for the sample 
(n=1661) 
Total stroke cost per case for 1-year follow-up 
Total stroke costs avoided 
Total Savings from BP Reduction 
ED Visits Avoided 
Hypertension visits resulting in an avoided ED 
visit (percent) 
# of initial hypertension visits to the ED that 
would have occurred if not for the GCCN 
(for n=1661) 
Cost per avoidable ED visit 
Total Savings from ED Visits Avoided 
TOTAL SAVINGS 
GCCN Expenditures 
# of hypertension visits per year 
# of hypertension visits for the sample 
(n=1661) 
Cost per GCCN visit 
Total GCCN Expenditures 
 
NET BENEFITS (Savings - Expenditures) 
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Management of hypertension in GCCN clinics indicates a 
good investment in the base-case and the best-case 
scenarios, based on the results of the cost-savings 
calculations shown in Table 3. Considering a hypothetical 
cohort of 100 patients receiving hypertension treatment in 
GCCN clinics over the course of a year, the estimate is that 
$13,500 and $5,700 will be saved from reductions in CHD 
events and stroke, respectively, and $46,600 will be saved 
due to fewer ED visits. When adjusted for the annual 
expenditures to treat 100 patients annually in GCCN clinics 
($41,250), the estimate is that for each $1 spent by GCCN 
clinics, there is an average savings of $1.60. This represents 
an annual savings of roughly $24,500 for each 100 patients 
screened and treated for hypertension in GCCN clinics. 
 
Although the worst-case scenario does not produce a 
favorable ROI, the economic returns are positive when key 
model inputs are varied one at a time, rather than 
simultaneously. Further, in comparison with other screening 
and treatment options for hypertensive patients, the GCCN 
may still represent a cost-effective option for managing 
hypertension in the uninsured population. Prevention costs 
money, and the money spent on prevention may well be 
worth the money spent on treatment in the long-term. 
 
Limitations 
There are three major limitations to this analysis. First, we 
used a healthcare system perspective, which is limited to 
costs to the clinic and other healthcare providers. The 
analysis does not include the costs of medications required 
to manage hypertension, and, although these are not costs 
that are realized by GCCN clinics, medications represent a 
cost to some part of the healthcare system (even if they are 
overstock and provided for “free” or reduced prices). From 
a societal perspective, the costs of medications would have 
been included, even if they were free to hypertension 
patients frequenting GCCN clinics. Costs to patients would 
also be included in the societal perspective, including any 
healthcare costs paid out-of-pocket and losses  in 
productivity associated with CHD and stroke events. 
Second, since incidence rates for CHD events and stroke in 
Georgia were not available, Georgia hospital discharge and 
death rates were used. These were from the OASIS data 
based on categories of disease that do not perfectly align 
with the CHD definitions provided in Law et al. (2009) and 
Song et al. (2013). The incidences of CHD and stroke are 
likely higher in the South; however, the present estimates, 
which are lower than those used by Song et al. (2013), do 
not reflect that knowledge. Consequently, the estimates of 
CHD and stroke events averted are likely to be conservative. 
 
Third, all costs related to the initial identification of the 
cohort of 1661 hypertensive patients were not included, as 
each clinic likely served multiple patrons per hypertension 
case identified. Since patient-level data were not available 
for the entire clinic population, the analysis of costs and 
benefits was limited to the treatment of the 1661 patients. 
Given the small number of clinics providing patient-level 
data (n=12), it is also possible that these sites are not a 
representative sample of all GCCN clinics and may manage 
patients more or less efficiently than others in the network. 
 
Implications for Public Health 
Based on results of these analyses, there is economic 
evidence to support investment in GCCN clinics across the 
state for the screening and treatment of hypertensive 
patients. Further, it is likely that the management of other 
chronic conditions in GCCN clinics would provide similar 
economic returns. For example, Fertig et al. (2012) 
conducted a case study in which they estimated the benefits 
and costs of a free clinic in Georgia providing general 
primary care services. By use of matched data from the 
clinic and its corresponding regional hospital on a sample of 
newly enrolled clinic patients, the authors found that 
patients’ non-urgent ED and inpatient costs at the hospital 
fell by $170 per patient in the year following clinic 
enrollment. After 3 years of sustained clinical management 
of chronic diseases, they estimated that the savings from 
reduced hospital utilization would offset clinic expenditures. 
In another study, Zhou et al. (2014) found that among a 
group of indigenous residents of Australia, primary care for 
renal disease and diabetes was the most cost-effective 
investment of clinical services, followed by hypertension 
and ischemic heart disease. 
 
Despite the demonstrated positive ROI for screening and 
treating hypertension in GCCN clinics and the likelihood of 
greater economic impact from comprehensive GCCN 
services, the network’s current patient capacity represents 
only a small fraction of the uninsured. In 2013, 23% of 
Georgians were uninsured, but GCCN clinics served only 
8.5% of this population (Kaiser Family Foundation, 2014). 
An efficient use of state resources may be to fund these 
clinics in order to expand the population served and 
consequently reduce uncompensated care costs for chronic 
disease management and avoidable ED visits. 
 
Although increased funding is essential to reach these goals, 
expanding the reach of free and charitable clinics in Georgia 
will necessitate more than financial support. First, an 
efficient and directed expansion will require collection and 
analysis of high-quality data including descriptions of the 
demographics, clinical profiles, and health needs of the 
patient population. Second, improvements in  technology 
and infrastructure may be needed to boost the care capacity 
of existing clinics. Finally, expansion will require volunteer 
hours from additional medical and administrative personnel 
needed to staff these clinics. Addressing these hurdles and 
extending the reach of GCCN clinics has the potential to 
provide cost-savings to the health system through cost- 
efficient identification, treatment, and management of 
chronic diseases and to reduce the adverse health outcomes 
associated with being uninsured for Georgia’s vulnerable 
populations. 
 
Many of the uninsured suffer from chronic diseases 
requiring regular monitoring and comprehensive treatment, 
and local clinics strive to meet these health needs. Clinics 
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also offer preventive services and patient education to a 
high-risk population lacking access to affordable primary 
care. In states forgoing Medicaid expansion, free and 
charitable clinics will continue to make up an important 
part of the healthcare safety net, and providing these clinics 
with sufficient resources for comprehensive disease 
management is a more efficient and compassionate use of 
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